Analyst target 12 Nov 19

Yangzijiang – may be ripe for a bounce (12 Nov 2019)

This week, besides Food Empire which caught my attention (click HERE), Yangzijiang (“YZJ”) also caught my attention for being a laggard. It has given up all the gains since its large 7% jump on 5 Nov 2019. Notwithstanding the recent mild profit taking, it seems to be holding up well above its uptrend line. Given that its results are just around the corner, it may be an opportune time to take a look at YZJ. Do take a look at the basis, and more importantly, the risks.   Basis A) Chart analysis – a breakout / breakdown seems to be […]

Table 2_Food Empire's peers

Food Empire – potential bullish chart development amid volume expansion (11 Nov 2019)

This week, Food Empire caught my attention with their potential bullish chart developments amid volume expansion. This may be an opportune time to take a look at Food Empire on the back of its potential bullish chart and strong results released this evening. Do take a look at the basis and more importantly, the risks.   Basis A) Chart looks positive with strengthening indicators and volume Based on Chart 1 below, Food Empire has been trading in six-month trading range $0.490 – 0.550 and is now on the verge of challenging its key resistance around $0.550 with increasing volume. It […]

Peer comparison 17 Sep 2019

Unusual – Challenging its key resistance $0.270 – 0.280 with volume expansion (4 Nov 2019)

Last Friday, Unusual Limited (“Unusual”) caught my attention. It is testing its key resistance $0.270 – 0.280, accompanied by an increase in volume for the past three days with above average volume in two out of the past three days. It closed at $0.275 on 4 Nov 2019. Day range 0.270 – 0.280. Furthermore, as its 2QFY20F results are just around the corner, it may be an opportune time to take a look at this stock.   Interesting points A) Chart looks positive with strengthening indicators and volume Based on Chart 1 below, Unusual has been challenging its key resistance […]

Chart 3_S&P500 chart 6 Sep 19

S&P500 at 2,979 – limited potential upside (8 Sep 19)

With reference to my earlier write-up (click HERE) titled “Why am I cautious going into July…”, July was coincidentally the peak for S&P500. Hang Seng touched an intraday high of 29,008 on 4 Jul 2019 before slumping 4,108 points to an intraday low of 24,900 on 15 Aug 2019 (Hang Seng closed at 26,691 on 6 Sep 2019.) Personally, given the current market levels and information, I am not comfortable to raise my current percentage invested from 53% to significant levels (say >80%). Why am I cautious in the market? Do read on…   Factors supporting my cautious basis Above […]

analyst 17 Jun 19

Halliburton trades at 9-year low price, amid 10-year low valuations (17 Jun 19)

Dear all This week, Halliburton (“HAL”) caught my attention as it closed at US$21.38 on 14 Jun 2019, lowest since 1 Jun 2010 and 7 Aug 2009, amid 10-year low valuations. Given the basis below, my personal view is that HAL may be presenting a favourable risk reward setup for a long trade.   Potential basis to long a)  At US$21.38, this is the lowest close since 1 Jun 2010. At 12.5x current PE and 1.9x P/BV (see Figure 1 below), these valuations seem attractive as compared to its 10Y average PE and P/BV 29.3x and 3.2x respectively; Figure 1: […]

Table 1_Best World peer comparison

Best World – down 47% in 2 months! Buying opportunity or falling knife? (12 Apr 19)

With reference to my 19 Sep 2018 write-up (click HERE), Best World has appreciated approximately 147% from $1.35 on 19 Sep 2018 to touch an intra-day high of $3.33 on 13 Feb 2019. At that time, Best World has dropped out of my watchlist after its incredible rally. However, with its recent 47% tumble from its all-time intra-day high $3.33 on 13 Feb 2019 to trade $1.76 on 12 Apr 2019, it seems interesting again. Is this a buying opportunity or falling knife?   Why is it interesting? a) Valuations are more attractive now Based on Bloomberg (see Table 1), Best World […]

Sing Medical – Chart seems to be strengthening (13 Feb 2019)

This week, Sing Medical’s (“SMG”) caught my attention. At the time of writing this write-up, SMG is trading +0.005 to $0.430. Day range 0.425 – 0.430.   Some interesting observations on SMG a) Chart seems to be strengthening Based on Chart 1 below, SMG seems to have breached the near term downtrend line established since Mar 2018. Today is T+7 of the sharp upmove dated 31 Jan 2019 thus, I guess those contra players (who plan to contra and not hold the stock) have already exited. Indicators such as OBV, RSI and MACD are strengthening. ADX last trades 34.5 on […]

Chart 1_record order book as of 10 Aug 2018

ISOTeam trades near 4 year low despite record order books and bright outlook (10 Jan 19)

ISOTeam (“ISO”) caught my attention. Despite sitting on a record order book, ISO has tumbled approximately 44% from an intra-day high of $0.385 on 10 Apr 2018 to close near a four year low at around $0.215 on 10 Jan 2019. The share price decline was attributable in part to its 4QFY18 surprise loss announced in Aug 2018 (financial year ends in Jun). Nevertheless, my gut feel is that 4QFY18 should mark the trough in earnings and results should improve on a quarter on quarter basis in the next few quarters. As this company is a potential turnaround play, I […]

SIA Engineering analyst target 26 Dec 18

SIA Engineering trades at 9-year low price and 10-year low valuations (26 Dec 18)

SIA Engineering (“SIE”) catches my attention this week because 1) Share price has fallen to the lows last seen in May 2009 – 9 +year low with negative news, more or less well known. It last trades at $2.20 on 26 Dec 2018. Based on Maybank’s report out this month, SIE management has flagged out challenges in their industry approximately two years ago –> on lower maintenance frequency required by newer aircraft and fleet growth at low cost carriers (“LCC”) requiring SIE to think of new solutions to reduce aircraft downtime at hangars; 2) At $2.20, RSI last trades at […]

Sing medical analyst target price 2 Oct 18

Sing Medical trades near one year low despite a 70% jump in 1HFY18 net profit! (3 Oct 2018)

This week, Sing Medical (“SMG”) caught my attention. SMG has dropped 39% from $0.725 on 18 Jul 2017 to trade $0.440 on 3 Oct 2018. My personal guess is part of the fall may be attributable to a) Lower, or no earnings growth for some of the healthcare players in FY18F. However, this is likely not the case for SMG, as analysts believe SMG is on track for a minimum 40% growth in FY18F net profit. It is noteworthy that SMG already posted a 70% jump in 1HFY18 net profit; b) Reduction in the general PE valuations ascribed to the […]